{
  "retracted": false,
  "timestamp": 1523318400000,
  "updates": [
    {
      "timestamp": 1574820714903,
      "identifier": {
        "doi": "10.1007/s40272-018-0291-3"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40272-017-0264-y"
  },
  "journal": "Pediatric Drugs",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in Japan"
}
